Sanofi Says Dengue Vaccine Succeeds in Late-Stage Trial

The French drug maker said its product reduced the incidence of dengue fever by 56 percent when tested on more than 10,000 children in Southeast Asia.

via NYT > Business Day http://ift.tt/1rwpIqM

via WordPress http://ift.tt/1m09jxM